Loading…
Loading…
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MSD and 80,000+ other tickers.
See exactly how MSD's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MSD and 80,000+ other tickers.
The Morgan Stanley Emerging Markets Debt Fund, Inc. (MSD) is a closed-end investment vehicle specializing in fixed income, managed by Morgan Stanley Investment Management Inc. Its core objective is to invest in debt instruments across global emerging market economies. The fund's portfolio predominantly comprises debt securities issued by sovereign governments, government-related entities, and corporations domiciled in or operating within these emerging nations. Additionally, it allocates capital to debt from organizations specifically formed to restructure the outstanding obligations of such…
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 6/30/26 7/15/26 Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Emerging Markets Debt Fund, Inc. MSD $0.15 Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. EDD $0.24 The amount of net investment income to be paid by the Funds is determined in accordance with federal income tax regulations. It.
[url="]Keysight Technologies, Inc.[/url] (NYSE: KEYS) today announced it has achieved a Hybrid eCall certification to the EN 18052:2025 standard from DEKRA. Th
Morgan Stanley Emerging Markets Debt Fund has rallied since 2022, driven by rising rates, macro improvements, and a weaker US dollar. MSD offers high-yield and diversified exposure to sovereign, corporate, and quasi-sovereign debt across less-tracked emerging markets. The fund maintains a stable distribution history, but recent trends show declining yields and rising risks in emerging markets.
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 3/31/2026 4/15/2026 Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Emerging Markets Debt Fund, Inc. MSD $0.14 Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. EDD $0.14 For more information call: 1-800-231-2608. The amount of net investment income to be paid by the Funds is determined in acc.
COPENHAGEN, Denmark, December 19, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has been informed that MSD (tradename of Merck & Co., Inc., Rahway, NJ, USA) will not exercise its option for Evaxion's Gonorrhea vaccine candidate EVX-B2. Consequently, Evaxion retains global rights to EVX-B2 and will look for another potential licensing partner.